Citric Acid

Citric Acid

SCHEMBL2835076

CN1CCC(Oc2ccc(Cl)c(Cl)c2)c2occc2C1.O=C(O)CC(O)(CC(=O)O)C(=O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 9/20 0.36
MEN1 known ✓ O00255 1/20 0.34
SIGMAR1 known ✓ Q99720 1/20 0.34
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CCR3 P51677 10/20 0.36
KCNH2 Q12809 5/20 0.35
LNPEP Q9UIQ6 1/20 0.35
KMT2A Q03164 1/20 0.34
FFAR4 Q5NUL3 2/20 0.34
SLC6A5 Q9Y345 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2838001 0.87 KDM4E (0.38) KDM4EALDH1A1CCR3HRH1SIGMAR1
SCHEMBL2839442 0.78 SLC6A4 (0.38) KDM4EALDH1A1KCNH2MEN1KMT2A
Citric Acid SCHEMBL2840328 0.78 CHRM3 (0.36) KDM4EALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL2837917 0.77 SLC6A4 (0.37) KDM4EALDH1A1KCNH2MEN1KMT2A
SCHEMBL2836692 0.72 ROCK2 (0.34) ALDH1A1
SCHEMBL2837126 0.72 HRH3 (0.39) KDM4EALDH1A1MEN1KMT2A
SCHEMBL2836717 0.71 SLC6A2 (0.35) KDM4EALDH1A1CCR3HRH1KCNH2
SCHEMBL2836555 0.70 KDM4E (0.38) KDM4EALDH1A1CCR3HRH1KCNH2
SCHEMBL2841183 0.70 HTR2A (0.40) KDM4EALDH1A1SLC6A5
SCHEMBL2841728 0.66 KDM4E (0.40) KDM4EALDH1A1CCR3HRH1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 HRH1 550/4885MEN1 3895/4885SIGMAR1 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.